Increased	O
risk	O
of	O
Post	B:C0432487
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
in	O
lung	O
transplant	I:C2063401
recipients	I:C2063401
with	O
cystic	O
fibrosis	I:C0010674
.	O

Increased	O
risk	O
of	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
in	O
lung	B:C2063401
transplant	I:C2063401
recipients	I:C2063401
with	O
cystic	O
fibrosis	I:C0010674
.	O

Increased	O
risk	O
of	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
in	O
lung	O
transplant	I:C2063401
recipients	I:C2063401
with	O
cystic	B:C0010674
fibrosis	I:C0010674
.	O

Post	B:C0432487
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
(	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
)	O
is	O
an	O
important	O
cause	O
of	O
morbidity	O
and	O
mortality	O
following	O
lung	O
transplantation	I:C0024128
.	O

Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
(	O
Post	B:C0432487
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
)	O
is	O
an	O
important	O
cause	O
of	O
morbidity	O
and	O
mortality	O
following	O
lung	O
transplantation	I:C0024128
.	O

Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
(	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
)	O
is	O
an	O
important	O
cause	O
of	O
morbidity	O
and	O
mortality	O
following	O
lung	B:C0024128
transplantation	I:C0024128
.	O

Recipients	O
with	O
cystic	B:C0010674
fibrosis	I:C0010674
(	O
cystic	O
fibrosis	I:C0010674
)	O
may	O
have	O
an	O
increased	O
risk	O
of	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
although	O
the	O
literature	O
is	O
limited	O
to	O
single	O
center	I:C0599755
cohorts	I:C0599755
.	O

Recipients	O
with	O
cystic	O
fibrosis	I:C0010674
(	O
cystic	B:C0010674
fibrosis	I:C0010674
)	O
may	O
have	O
an	O
increased	O
risk	O
of	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
although	O
the	O
literature	O
is	O
limited	O
to	O
single	O
center	I:C0599755
cohorts	I:C0599755
.	O

Recipients	O
with	O
cystic	O
fibrosis	I:C0010674
(	O
cystic	O
fibrosis	I:C0010674
)	O
may	O
have	O
an	O
increased	O
risk	O
of	O
Post	B:C0432487
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
although	O
the	O
literature	O
is	O
limited	O
to	O
single	O
center	I:C0599755
cohorts	I:C0599755
.	O

Recipients	O
with	O
cystic	O
fibrosis	I:C0010674
(	O
cystic	O
fibrosis	I:C0010674
)	O
may	O
have	O
an	O
increased	O
risk	O
of	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
although	O
the	O
literature	B:C0023866
is	O
limited	O
to	O
single	O
center	I:C0599755
cohorts	I:C0599755
.	O

Recipients	O
with	O
cystic	O
fibrosis	I:C0010674
(	O
cystic	O
fibrosis	I:C0010674
)	O
may	O
have	O
an	O
increased	O
risk	O
of	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
although	O
the	O
literature	O
is	O
limited	O
to	O
single	B:C0599755
center	I:C0599755
cohorts	I:C0599755
.	O

Our	O
primary	O
aim	O
is	O
to	O
examine	O
Post	B:C0432487
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
in	O
an	O
adult	O
lung	O
transplant	I:C0024128
population	O
by	O
utilizing	O
the	O
International	O
Society	I:C0282574
for	I:C0282574
Heart	I:C0282574
and	I:C0282574
Lung	I:C0282574
Transplantation	I:C0282574
Registry	I:C0282574
.	O

Our	O
primary	O
aim	O
is	O
to	O
examine	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
in	O
an	O
adult	O
lung	B:C0024128
transplant	I:C0024128
population	O
by	O
utilizing	O
the	O
International	O
Society	I:C0282574
for	I:C0282574
Heart	I:C0282574
and	I:C0282574
Lung	I:C0282574
Transplantation	I:C0282574
Registry	I:C0282574
.	O

Our	O
primary	O
aim	O
is	O
to	O
examine	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
in	O
an	O
adult	O
lung	O
transplant	I:C0024128
population	B:C1257890
by	O
utilizing	O
the	O
International	O
Society	I:C0282574
for	I:C0282574
Heart	I:C0282574
and	I:C0282574
Lung	I:C0282574
Transplantation	I:C0282574
Registry	I:C0282574
.	O

Our	O
primary	O
aim	O
is	O
to	O
examine	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
in	O
an	O
adult	O
lung	O
transplant	I:C0024128
population	O
by	O
utilizing	O
the	O
International	B:C0282574
Society	I:C0282574
for	I:C0282574
Heart	I:C0282574
and	I:C0282574
Lung	I:C0282574
Transplantation	I:C0282574
Registry	I:C0282574
.	O

We	O
studied	B:C2603343
30,598	O
adult	O
recipients	O
of	O
lung	O
transplants	I:C0024128
performed	O
between	O
1999	O
and	O
2011	O
.	O

We	O
studied	O
30,598	O
adult	O
recipients	B:C1709854
of	O
lung	O
transplants	I:C0024128
performed	O
between	O
1999	O
and	O
2011	O
.	O

We	O
studied	O
30,598	O
adult	O
recipients	O
of	O
lung	B:C0024128
transplants	I:C0024128
performed	O
between	O
1999	O
and	O
2011	O
.	O

The	O
primary	O
outcome	O
was	O
development	O
of	O
and	O
time	O
to	O
Post	B:C0432487
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
.	O

In	O
addition	O
to	O
indication	O
for	O
transplant	B:C0040732
,	O
other	O
predictors	O
examined	O
included	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
(	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
)	O
and	O
cytomegalovirus	O
(	O
cytomegalovirus	O
)	O
serostatus	O
,	O
gender	O
,	O
and	O
age	O
.	O

In	O
addition	O
to	O
indication	O
for	O
transplant	O
,	O
other	O
predictors	O
examined	O
included	O
Epstein	B:C0014644
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
(	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
)	O
and	O
cytomegalovirus	O
(	O
cytomegalovirus	O
)	O
serostatus	O
,	O
gender	O
,	O
and	O
age	O
.	O

In	O
addition	O
to	O
indication	O
for	O
transplant	O
,	O
other	O
predictors	O
examined	O
included	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
(	O
Epstein	B:C0014644
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
)	O
and	O
cytomegalovirus	O
(	O
cytomegalovirus	O
)	O
serostatus	O
,	O
gender	O
,	O
and	O
age	O
.	O

In	O
addition	O
to	O
indication	O
for	O
transplant	O
,	O
other	O
predictors	O
examined	O
included	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
(	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
)	O
and	O
cytomegalovirus	B:C0010825
(	O
cytomegalovirus	O
)	O
serostatus	O
,	O
gender	O
,	O
and	O
age	O
.	O

In	O
addition	O
to	O
indication	O
for	O
transplant	O
,	O
other	O
predictors	O
examined	O
included	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
(	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
)	O
and	O
cytomegalovirus	O
(	O
cytomegalovirus	B:C0010825
)	O
serostatus	O
,	O
gender	O
,	O
and	O
age	O
.	O

In	O
addition	O
to	O
indication	O
for	O
transplant	O
,	O
other	O
predictors	O
examined	O
included	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
(	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
)	O
and	O
cytomegalovirus	O
(	O
cytomegalovirus	O
)	O
serostatus	B:C1300950
,	O
gender	O
,	O
and	O
age	O
.	O

Outcomes	O
were	O
assessed	O
with	O
univariable	O
and	O
multivariable	B:C0010235
Cox	I:C0010235
proportional	I:C0010235
hazard	I:C0010235
models	I:C0010235
to	O
obtain	O
hazard	O
ratios	O
(	O
HR	O
)	O
.	O
17	O
%	O
of	O
the	O
cohort	O
had	O
a	O
diagnosis	O
of	O
cystic	O
fibrosis	I:C0010674
.	O

Outcomes	O
were	O
assessed	O
with	O
univariable	O
and	O
multivariable	O
Cox	I:C0010235
proportional	I:C0010235
hazard	I:C0010235
models	I:C0010235
to	O
obtain	O
hazard	O
ratios	O
(	O
HR	O
)	O
.	O
17	O
%	O
of	O
the	O
cohort	B:C0599755
had	O
a	O
diagnosis	O
of	O
cystic	O
fibrosis	I:C0010674
.	O

Outcomes	O
were	O
assessed	O
with	O
univariable	O
and	O
multivariable	O
Cox	I:C0010235
proportional	I:C0010235
hazard	I:C0010235
models	I:C0010235
to	O
obtain	O
hazard	O
ratios	O
(	O
HR	O
)	O
.	O
17	O
%	O
of	O
the	O
cohort	O
had	O
a	O
diagnosis	B:C0011900
of	O
cystic	O
fibrosis	I:C0010674
.	O

Outcomes	O
were	O
assessed	O
with	O
univariable	O
and	O
multivariable	O
Cox	I:C0010235
proportional	I:C0010235
hazard	I:C0010235
models	I:C0010235
to	O
obtain	O
hazard	O
ratios	O
(	O
HR	O
)	O
.	O
17	O
%	O
of	O
the	O
cohort	O
had	O
a	O
diagnosis	O
of	O
cystic	B:C0010674
fibrosis	I:C0010674
.	O

Post	B:C0432487
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
developed	O
in	O
2	O
%	O
of	O
cystic	O
fibrosis	I:C0010674
recipients	O
compared	O
to	O
1	O
%	O
for	O
non-CF	O
recipients	I:C2063401
(	O
p<0.001	O
)	O
.	O

Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
developed	O
in	O
2	O
%	O
of	O
cystic	B:C0010674
fibrosis	I:C0010674
recipients	O
compared	O
to	O
1	O
%	O
for	O
non-CF	O
recipients	I:C2063401
(	O
p<0.001	O
)	O
.	O

Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
developed	O
in	O
2	O
%	O
of	O
cystic	O
fibrosis	I:C0010674
recipients	O
compared	O
to	O
1	O
%	O
for	O
non-CF	B:C2063401
recipients	I:C2063401
(	O
p<0.001	O
)	O
.	O

Compared	O
to	O
non-CF	B:C2063401
recipients	I:C2063401
,	O
cystic	O
fibrosis	I:C0010674
recipients	O
had	O
higher	O
prevalence	O
of	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
CMV	O
seronegativity	I:C2919629
and	O
higher	O
prevalences	O
of	O
high	O
risk	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
cytomegalovirus	O
mismatch	O
(	O
D+/R-	O
)	O
.	O

Compared	O
to	O
non-CF	O
recipients	I:C2063401
,	O
cystic	B:C0010674
fibrosis	I:C0010674
recipients	O
had	O
higher	O
prevalence	O
of	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
CMV	O
seronegativity	I:C2919629
and	O
higher	O
prevalences	O
of	O
high	O
risk	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
cytomegalovirus	O
mismatch	O
(	O
D+/R-	O
)	O
.	O

Compared	O
to	O
non-CF	O
recipients	I:C2063401
,	O
cystic	O
fibrosis	I:C0010674
recipients	O
had	O
higher	O
prevalence	O
of	O
Epstein	B:C0014644
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
CMV	O
seronegativity	I:C2919629
and	O
higher	O
prevalences	O
of	O
high	O
risk	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
cytomegalovirus	O
mismatch	O
(	O
D+/R-	O
)	O
.	O

Compared	O
to	O
non-CF	O
recipients	I:C2063401
,	O
cystic	O
fibrosis	I:C0010674
recipients	O
had	O
higher	O
prevalence	O
of	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
CMV	B:C2919629
seronegativity	I:C2919629
and	O
higher	O
prevalences	O
of	O
high	O
risk	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
cytomegalovirus	O
mismatch	O
(	O
D+/R-	O
)	O
.	O

Compared	O
to	O
non-CF	O
recipients	I:C2063401
,	O
cystic	O
fibrosis	I:C0010674
recipients	O
had	O
higher	O
prevalence	O
of	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
CMV	O
seronegativity	I:C2919629
and	O
higher	O
prevalences	O
of	O
high	O
risk	O
Epstein	B:C0014644
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
cytomegalovirus	O
mismatch	O
(	O
D+/R-	O
)	O
.	O

Compared	O
to	O
non-CF	O
recipients	I:C2063401
,	O
cystic	O
fibrosis	I:C0010674
recipients	O
had	O
higher	O
prevalence	O
of	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
CMV	O
seronegativity	I:C2919629
and	O
higher	O
prevalences	O
of	O
high	O
risk	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
and	O
cytomegalovirus	B:C0010825
mismatch	O
(	O
D+/R-	O
)	O
.	O

There	O
is	O
a	O
significant	O
association	O
between	O
cystic	B:C0010674
fibrosis	I:C0010674
and	O
the	O
development	O
of	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
[	O
HR	O
1.66	O
(	O
95	O
%	O
CI	O
1.30	O
-	O
2.12	O
)	O
]	O
.	O

There	O
is	O
a	O
significant	O
association	O
between	O
cystic	O
fibrosis	I:C0010674
and	O
the	O
development	O
of	O
Post	B:C0432487
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
[	O
HR	O
1.66	O
(	O
95	O
%	O
CI	O
1.30	O
-	O
2.12	O
)	O
]	O
.	O

Stratified	O
multivariable	O
analysis	O
controlling	O
for	O
age	O
revealed	O
Epstein	B:C0014644
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	O
non-CF	O
recipients	I:C2063401
have	O
an	O
almost	O
2	O
fold	O
increased	O
risk	O
of	O
developing	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
,	O
whereas	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	O
cystic	O
fibrosis	I:C0010674
recipients	O
had	O
an	O
almost	O
6.5	O
fold	O
increased	O
risk	O
.	O

Stratified	O
multivariable	O
analysis	O
controlling	O
for	O
age	O
revealed	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	B:C1513916
non-CF	O
recipients	I:C2063401
have	O
an	O
almost	O
2	O
fold	O
increased	O
risk	O
of	O
developing	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
,	O
whereas	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	O
cystic	O
fibrosis	I:C0010674
recipients	O
had	O
an	O
almost	O
6.5	O
fold	O
increased	O
risk	O
.	O

Stratified	O
multivariable	O
analysis	O
controlling	O
for	O
age	O
revealed	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	O
non-CF	B:C2063401
recipients	I:C2063401
have	O
an	O
almost	O
2	O
fold	O
increased	O
risk	O
of	O
developing	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
,	O
whereas	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	O
cystic	O
fibrosis	I:C0010674
recipients	O
had	O
an	O
almost	O
6.5	O
fold	O
increased	O
risk	O
.	O

Stratified	O
multivariable	O
analysis	O
controlling	O
for	O
age	O
revealed	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	O
non-CF	O
recipients	I:C2063401
have	O
an	O
almost	O
2	O
fold	O
increased	O
risk	O
of	O
developing	O
Post	B:C0432487
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
,	O
whereas	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	O
cystic	O
fibrosis	I:C0010674
recipients	O
had	O
an	O
almost	O
6.5	O
fold	O
increased	O
risk	O
.	O

Stratified	O
multivariable	O
analysis	O
controlling	O
for	O
age	O
revealed	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	O
non-CF	O
recipients	I:C2063401
have	O
an	O
almost	O
2	O
fold	O
increased	O
risk	O
of	O
developing	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
,	O
whereas	O
Epstein	B:C0014644
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	O
cystic	O
fibrosis	I:C0010674
recipients	O
had	O
an	O
almost	O
6.5	O
fold	O
increased	O
risk	O
.	O

Stratified	O
multivariable	O
analysis	O
controlling	O
for	O
age	O
revealed	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	O
non-CF	O
recipients	I:C2063401
have	O
an	O
almost	O
2	O
fold	O
increased	O
risk	O
of	O
developing	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
,	O
whereas	O
Epstein	O
-	I:C0014644
Barr	I:C0014644
virus	I:C0014644
negative	O
cystic	B:C0010674
fibrosis	I:C0010674
recipients	O
had	O
an	O
almost	O
6.5	O
fold	O
increased	O
risk	O
.	O

cystic	B:C0010674
fibrosis	I:C0010674
recipients	O
have	O
a	O
higher	O
risk	O
for	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
compared	O
to	O
non-CF	O
recipients	I:C2063401
.	O

cystic	O
fibrosis	I:C0010674
recipients	O
have	O
a	O
higher	O
risk	O
for	O
Post	B:C0432487
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
compared	O
to	O
non-CF	O
recipients	I:C2063401
.	O

cystic	O
fibrosis	I:C0010674
recipients	O
have	O
a	O
higher	O
risk	O
for	O
Post	O
-	I:C0432487
transplant	I:C0432487
lymphoproliferative	I:C0432487
disease	I:C0432487
compared	O
to	O
non-CF	B:C2063401
recipients	I:C2063401
.	O

Further	O
studies	B:C2603343
are	O
needed	O
to	O
account	O
for	O
additional	O
risk	O
factors	I:C0035648
and	O
management	O
in	O
this	O
population	O
post	I:C2063401
-	I:C2063401
transplant	I:C2063401
.	O

Further	O
studies	O
are	O
needed	O
to	O
account	O
for	O
additional	O
risk	B:C0035648
factors	I:C0035648
and	O
management	O
in	O
this	O
population	O
post	I:C2063401
-	I:C2063401
transplant	I:C2063401
.	O

Further	O
studies	O
are	O
needed	O
to	O
account	O
for	O
additional	O
risk	O
factors	I:C0035648
and	O
management	B:C0035649
in	O
this	O
population	O
post	I:C2063401
-	I:C2063401
transplant	I:C2063401
.	O

Further	O
studies	O
are	O
needed	O
to	O
account	O
for	O
additional	O
risk	O
factors	I:C0035648
and	O
management	O
in	O
this	O
population	B:C2063401
post	I:C2063401
-	I:C2063401
transplant	I:C2063401
.	O

